Use of mouthwashes to prevent transmission of COVID-19. Review
Keywords:
Rinses, COVID-19, SARS-CoVAbstract
The evolutionary process of the SARS-CoV2 disease identified as COVID-19, is related to the oral cavity and the high percentage of pathogenicity in the throat the first 5-6 days. The transmission of the virus takes place through the inhalation of nanoparticles from the air through expectorations, sneezing or saliva, with high viral loads in infected individuals as well as in infected asymptomatic patients; oral transmission of SARS_CoV2 being at high risk. The proposal of the use of mouthwashes in preventive dentistry is to inactivate or decrease the viral load of SARS-CoV2 in the oral cavity of infected patients and reduce its transmission at the time of receiving dental care. The purpose of this article is to assess and know the best alternative to mouthwash through scientific research this year. Concluding that povidone-iodine-based rinses in a minimum concentration of 0.5% are effective against SARS-CoV2 at a contact time of 15 seconds as the first alternative, followed by 1% hydrogen peroxide at a contact time of 1min.
Downloads
References
Sigua E, Bernal J, Lanata A, Sanchez C, Rodriguez J, Haidar Z, et al. COVID-19 y la Odontología: una Revisión de las recomendaciones y perspectivas para Latinoamérica. Int. J. Odontostomat. 2020; 14(3):299-302. Doi: 10.4067/S0718-381X2020000300299
Corruel F, Conte M, Fisher J, Souza L, Dussart C, Llodra J, et al. COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression. J Clin Med. 2020; 9(4):1-2. Doi: 10.3390 / jcm9041126
Herrera D, Serrano J, Roldán S, Sanz M. Is the oral cavity relevant in SARS-CoV-2 pandemic?. 2020; 24: 2927. Doi: 10.1007 / s00784-020-03413-2
McDonnell G, Rusell A. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev.1999; 12 (1): 156. PMID: 9880479
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Trasmission routes of 2019-nCoV and controls in dental practiceransmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020; 12 (9):4. Doi: https://doi.org/10.1038/s41368-020-0075-9
Rodriguez R. Vademécum Académico de Medicamentos. 6th ed. España: McGraw-Hill Interamericana de España; 2015. Disponible en: 978-607-02-4172-7
Frank S, Capriotti J, Brown S, Tessema B. EraPovidone-Iodone Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Eras. 2020: 2-4-5-6. Doi: 10.1177 / 0145561320932318
Kirk-Bayley J, Sunkaraneni S, Challacombe E. The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers. 2020: 4-5
Disponible en SSRN: https://ssrn.com/abstract=3563092 o http://dx.doi.org/10.2139/ssrn.3563092
Mady L, Kubik M, Baddour K, Snyderman C, Rowan N. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol. 2020; 105: 104724. Doi: 10.1016/j.oraloncology.2020.104724
Parhar H, Tasche K, Brody R, Weinstein G, O'Malley B, Shanti R, et al.Topical preparations to reduce SARS‐CoV ‐2 aerosolization in head and
neck mucosal surgery. Head Neck. 2020; 42 (6): 1270. Doi: https://doi.org/10.1002/hed.26200
Nagatake T, Ahmed K, Oishi K. Prevention of Respiratory Infections by Povidone-Iodine Gargle. 2002; 204(1): 32. Doi: https://doi.org/10.1159/000057722
Kitamura T, Satomura K, Kawamura T, Yamada S, Takashima K, Suganuma N, et al. Can We Prevent Influenza-like Illnesses by Gargling?. Internal Medicine. 2007; 46(18): 1623 Doi: 10.2169 / internalmedicine.46.0104
Sato S, Miyake M, Hazama A, Omori K. Povidone-iodine-induced cell death in cultured human epithelial HeLa cells and rat oral mucosal tissue. Drug Chem Toxicol. 2014; 37(3): 269-271. doi: 10.3109 / 01480545.2013.846364
Hitosugi, T., Tsukamoto, M. & Yokoyama, T. Pneumonia due to aspiration of povidine iodine after preoperative disinfection of the oral cavity. Oral Maxillofac Surg. 2020; 23: 507–509 Doi: https://doi.org/10.1007/s10006-019-00800-2
Choi W, Park C, Son K, Cheon J. Aspiration pneumonitis due to povidone-iodine aspiration during a facial bone fracture reduction operation. J Craniofac Surg. 2014; 25(2): e172. doi: 10.1097 / SCS.0000000000000526
Brida A, Pelletier J, Westover J, Frank S, Brown S, Tessema B. Rapid In‐Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Using Povidone‐Iodine Oral Antiseptic Rinse. Journals of Prosthodontics. 2020 : 2-3. Doi: 10.1111 / jopr.13209
Brida A, Pelletier J, Westover J, Frank S, Brown S, Tessema B. Comparison of In Vitro Inactivation of SARS CoV‐2 with Hydrogen Peroxide and Povidone‐Iodine Oral Antiseptic Rinses. Journals of Prosthodontics. 2020 : 6-7-8. Doi: 10.1111 / jopr.13220
Kelly N, Nic Íomhair A, McKenna G. Can oral rinses play a role in preventing transmission of Covid 19 infection?. Dent basado en Evid. 2020; 21 (2): 42. Doi: https://doi.org/10.1038/s41432-020-0099-1
Ministerio de Salud del Perú. 2020. Directiva Sanitaria
N°100/MINSA/2020/DGIESP, Manejo de la atencion estomatológica en el contexto de la pandemia por COVID-19. Resolución Ministerial N° 288-2020-MINSA.
O'Donnell V, Thomas D, Stanton R, Maillard J, Murphy R, Jones S, et al, Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. Function. 2020; 1(1): 7. Doi:https://doi.org/10.1093/function/zqaa002
Tessema B, Frank S, Bidra A. SARS-CoV-2 SARS‐CoV‐2 Viral Inactivation Using Low Dose Povidone‐Iodine Oral Rinse—Immediate Application for the Prosthodontic Practice. Journals Prosthodontics. 2020. Doi: 10.1111 / jopr.13207
Downloads
Published
Issue
Section
License
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) posterior al proceso de aprobación del manuscrito, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada.
